title: [Severe local cutaneous necrosis during treatment with interferon-alpha and ribavirin for chronic viral hepatitis C].
authors.forename: V
authors.initials: V
authors.lastname: de Ledinghen
authors.forename: E
authors.initials: E
authors.lastname: Brudieux
authors.forename: M
authors.initials: M
authors.lastname: Beylot-Barry
authors.forename: G
authors.initials: G
authors.lastname: Belleannee
authors.forename: M S
authors.initials: MS
authors.lastname: Doutre
authors.forename: P
authors.initials: P
authors.lastname: Couzigou
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D009336:Necrosis; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*; D012867:Skin / Q000473:pathology*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin